Latin America Parenteral Nutrition Market (2026 - 2033)

Latin America Parenteral Nutrition Market Summary

The Latin America parenteral nutrition market size was valued at USD 272.6 million in 2025 and is projected to grow from USD 288.0 million in 2026 to USD 414.4 million by 2033, at a CAGR of 5.3% from 2026 to 2033. This growth is attributed to the high prevalence of hospital malnutrition, the increasing adoption of nutritional screening and medical nutrition therapy, the expansion of multidisciplinary nutrition-support services, and the growing clinical awareness of parenteral nutrition across Latin American hospitals.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Market Dynamics

The Latin America parenteral nutrition industry’s growth is driven by the high prevalence of hospital malnutrition, increasing adoption of medical nutrition therapy, and growing demand for specialized nutritional support. Rising use of nutritional screening, expanding critical care and oncology services, and increasing adoption of enteral feeding across hospitals and homecare settings are supporting market growth.

Market Concentration & Characteristics

The degree of innovation in the market is moderate to high, supported by advancements in lipid emulsions, amino acid formulations, micronutrient preparations, and multi-chamber bag technologies. Manufacturers and healthcare providers are increasingly focused on improving formulation stability, nutrient delivery, preparation efficiency, and patient-specific nutritional management. The growing availability of standardized and ready-to-use PN solutions is also supporting greater consistency in nutritional therapy across hospital settings.

The level of mergers, acquisitions, and collaboration activities in the Latin America parenteral nutrition market is low to moderate. Companies and healthcare organizations are primarily pursuing collaborations to strengthen clinical nutrition services, expand access to specialized nutritional support, improve home-based PN delivery, and enhance regional distribution capabilities.

To learn more about this report, Download Free Sample Report

The impact of regulations on the Latin America parenteral nutrition industry is high, as manufacturers must comply with country-specific requirements governing product registration, composition, quality, labeling, manufacturing, and patient safety. Regulatory requirements differ across individual Latin American markets, creating additional compliance considerations for companies operating across multiple countries. For instance, in Brazil, ANVISA introduced a revised food regulatory framework in 2024 that applies risk-based approaches to product regularization and maintains pre-market registration requirements for specified nutrition products, illustrating the importance of regulatory compliance in the regional nutrition market.

Country expansion presents an opportunity in the Latin America parenteral nutrition market, as manufacturers and nutrition-support providers can strengthen distribution networks and extend access to specialized PN products across underserved markets. Differences in healthcare infrastructure, hospital capacity, and adoption of specialized nutritional therapies create opportunities to expand beyond established markets such as Brazil and Mexico into Argentina and other Latin American countries, including through home-based nutritional support.

Analyst Perspective

The market is relatively consolidated, with a limited number of established manufacturers holding significant market shares. Market access is largely driven by hospital and institutional procurement processes, where product quality, regulatory compliance, supply reliability, and pricing influence supplier selection. The market also depends on established distribution networks and the ability to supply a broad range of PN formulations to meet varying clinical requirements. These factors create competitive advantages for established players, while new entrants face challenges in building institutional relationships, meeting procurement requirements, and ensuring consistent product availability across the region.

Nutrient Type Insights

The single dose amino acid solution segment dominated the Latin America parenteral nutrition market with a revenue share of 30.0% in 2025. This dominance is supported by the central role of amino acids as the primary protein source in parenteral nutrition and their broad use in patients unable to obtain adequate protein through oral or enteral nutrition. These solutions are available in different concentrations, allowing nutritional therapy to be adjusted according to patient requirements, fluid restrictions, clinical condition, and route of administration. Their use across critically ill, surgical, oncology, gastrointestinal, and nutritionally deficient patients supports demand across hospitals and other specialized care settings.

The trace elements segment is expected to grow at the fastest CAGR of 7.8% over the forecast period from 2026 to 2023. This growth is supported by the role of trace elements, including zinc, copper, selenium, manganese, and chromium, in immune function, antioxidant defense, and metabolic processes during long-term PN. Demand for multi-nutrient PN formulations containing trace elements is reflected in institutional procurement. For instance, in December 2025, the University Hospital of Ponta Grossa in Paraná, Brazil, issued a procurement for PN preparations containing amino acids, lipid emulsions, electrolytes, trace elements, vitamins, and other components.

Formulation & Delivery Format Insights

The compounded / hospital pharmacy-prepared PN segment dominated the Latin America parenteral nutrition industry in 2025. Segment growth is attributed to the flexibility to customize nutrient composition based on individual patient requirements, the increasing use of PN among critically ill and postoperative patients, the demand for tailored nutritional support for patients with complex clinical conditions, and the widespread availability of hospital pharmacy compounding services across acute care and long-term care settings.

The premixed / multi-chamber bags segment is expected to grow at the fastest CAGR from 2026 to 2033, driven by standardized formulations, reduced preparation requirements, and efficient PN administration across hospital and homecare settings. According to an April 2025 multicenter prospective study published in Nutrition in Clinical Practice, home parenteral nutrition was evaluated across several healthcare centers in Argentina, including Hospital Privado Universitario de Córdoba, Fundación Favaloro, Hospital Italiano La Plata, and Sanatorio Allende, with Fresenius Kabi Argentina as one of the participating organizations. The study compared home PN with hospital PN, highlighting the role of structured home-based PN delivery in Latin America.

Stage Insights

The adults segment dominated the Latin America parenteral nutrition market with a revenue share in 2025, driven by the high prevalence of chronic diseases and critical conditions among adults requiring nutritional support, increasing demand for parenteral nutrition during disease management and postoperative recovery, longer treatment requirements among patients with severe gastrointestinal dysfunction, and widespread use of PN across hospitals, intensive care units, and long-term care settings.

The pediatrics segment is expected to grow significantly over the forecast period, driven by the need for individualized PN formulations for children with critical illnesses, gastrointestinal disorders, intestinal failure, and nutritional deficiencies. For instance, a study published in January 2025 in the Journal of Parenteral and Enteral Nutrition by researchers at Universidade Estadual de Campinas, Brazil, evaluated 264 hospitalized children receiving PN, of whom 81.8% were intensive-care patients and 36.1% were malnourished. The study found that PN required customization in pediatric patients due to conditions such as renal or liver failure, inadequate energy-protein intake, and elevated mineral or triglyceride levels, highlighting the need for specialized pediatric PN formulations in Latin American clinical settings.

Indication Insights

The malabsorption/GI disorder/diarrhea segment dominated the market, accounting for a revenue share of 26.1% in 2025. This large share is driven by the need for intravenous nutritional support among patients with intestinal failure, severe malabsorption, short bowel syndrome, and gastrointestinal obstruction when oral or enteral nutrition is inadequate or inappropriate. For instance, the RESTORE Registry, published in October 2024, enrolled 167 patients with short-bowel-syndrome-related chronic intestinal failure across 20 specialized centers in Latin America. Among adults, postsurgical complications accounted for 37% of cases and intestinal ischemia for 25%, while 45.6% remained under follow-up, highlighting the ongoing need for specialized PN management across the region.

The pain management segment is expected to grow at the fastest CAGR over the forecast period. The segment growth is driven by nutritional challenges among patients undergoing major surgery, cancer treatment, or prolonged hospitalization. Pain-related conditions and intensive medical interventions can limit oral intake, increasing the need for PN when oral or enteral nutrition is inadequate. Growing integration of nutritional support into hospital care further supports segment growth.

Sales Channel Insights

The institutional channel dominated the Latin America parenteral nutrition industry, accounting for a revenue share of 98.5% in 2025, driven by regular hospital procurement, clinical monitoring requirements, and demand for specialized nutritional support among critically ill and post-surgical patients. For instance, in July 2025, the Hospital das Clínicas of the Federal University of Minas Gerais (HC-UFMG) in Brazil opened an electronic procurement process for the periodic purchase of compounded PN formulations standardized by the institution over 12 months, highlighting recurring institutional demand for PN products.

To learn more about this report, Download Free Sample Report

The online sales channel is expected to grow at the fastest CAGR of 9.9% during the forecast period, driven by the expansion of digital healthcare commerce and the increasing online purchase of healthcare products. According to VML’s Health Future Shopper 2025 LATAM report, 41% of consumers in Argentina purchase healthcare products from online supermarkets, while 65% of Latin American health shoppers report that products recommended by online marketplaces influence their purchasing decisions. This trend supports the development of digital distribution pathways for specialized nutrition products, particularly for home-based care.

Regional Insights

Brazil’s parenteral nutrition market held the largest regional share of 29.5% in 2025. The market growth is driven by demand for specialized nutritional support across hospitals and critical care settings, supported by the country’s established healthcare infrastructure and the need to manage complex clinical conditions. Institutional procurement and public-sector tenders influence purchasing patterns, while demand for customized nutrient formulations creates opportunities for specialized manufacturers. However, pricing pressures, affordability constraints, and regulatory requirements influence market access and competitive dynamics.

Mexico Parenteral Nutrition Market Trends

The Mexico parenteral nutrition market is driven by established hospital demand for intravenous nutritional therapy among critically ill and hospitalized patients who cannot meet nutritional requirements through oral or enteral feeding. The availability of standardized PN formulations in Mexico’s public health system supports institutional demand; the 2025 National Compendium of Health Supplies includes three-chamber PN bags in 1,000 mL, 1,500 mL, and 2,000 mL presentations containing lipids, amino acids, electrolytes, and glucose for patients when oral or enteral feeding is impossible, insufficient, or contraindicated.

South America Parenteral Nutrition Market Trends

Growth of the parenteral nutrition market in South America is driven by the increasing need for specialized nutritional support among hospitalized, critically ill, and nutritionally at-risk patients. The rising prevalence of chronic diseases, cancer, and gastrointestinal disorders is driving demand for PN products, including amino acids, lipid emulsions, vitamins, and trace elements. Expanding hospital infrastructure and clinical nutrition services further support PN adoption across inpatient, specialized care, and homecare settings.

Central America Parenteral Nutrition Market Trends

Central America is a developing region in the Latin America parenteral nutrition industry. The rising demand for clinical nutrition support in intensive care and other high-acuity hospital settings is driving market growth. Growing adoption of clinical nutrition practices and greater recognition of the role of nutritional support in patient management are supporting the use of parenteral nutrition across hospitals and intensive care settings.

Caribbean Parenteral Nutrition Market Trends

The Caribbean parenteral nutrition market is expected to grow at the fastest CAGR during the forecast period. The market growth is driven by the increasing need for specialized nutritional therapy among hospitalized, critically ill, and nutritionally vulnerable patients. The rising burden of chronic diseases, cancer, gastrointestinal disorders, surgical conditions, and other illnesses that affect adequate nutrient intake is contributing to demand for parenteral nutrition across hospital and specialized care settings.

Key Latin America Parenteral Nutrition Company Insights

Key players in the Latin America parenteral nutrition market are strengthening their positions through portfolio expansion, ready-to-use and multi-chamber PN solutions, specialized formulation development, regulatory approvals, manufacturing expansion, distribution partnerships, and geographic expansion.

Established companies such as Baxter, Fresenius Kabi AG, B. Braun Melsungen AG, and Grifols, S.A. leverage broad parenteral nutrition portfolios, established hospital relationships, manufacturing capabilities, and extensive distribution networks, while regional and emerging players such as Aculife, UNIDOSSIS, and SAFE (PiSA Farmacéutica) focus on specialized nutritional-support solutions, sterile compounding services, regional distribution, and country-specific hospital requirements.

Key Latin America Parenteral Nutrition Companies

• Baxter

• Grifols, S.A.

• Fresenius Kabi AG

• B. Braun Melsungen AG

• Aculife

• UNIDOSSIS

• SAFE (PiSA Farmacéutica)

• Cfarma

Recent Developments

• In September 2025, Baxter reported that it had supplied more than 145,000 ready-to-use parenteral nutrition bags for adults and babies in Mexico over the preceding three years. The development highlights Baxter’s continued expansion and utilization of its ready-to-use parenteral nutrition portfolio across the Mexican hospital market.

• In August 2025, Fresenius Kabi reported good development in its Nutrition business in Latin America, alongside continued expansion of its clinical-nutrition portfolio globally. The company identifies nutrition as a key growth vector and states that its portfolio includes parenteral nutrition products, supporting its continued commercial presence in the Latin American nutrition market.

Latin America Parenteral Nutrition Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Latin America parenteral nutritionmarket report based on nutrient type, formulation & delivery format, stage type, indication, sales channel, and region:

• Nutrient Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Carbohydrates

  • Parenteral Lipid Emulsion

  • Single Dose Amino Acid Solution

  • Trace Elements

  • Vitamins & Minerals

• Stage Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Adult

    • Other Pediatrics

    • Neonatal / Preterm

  • Pediatrics

• Formulation & Delivery Format Outlook (Revenue, USD Million, 2021 - 2033)

  • Premixed / Multi-Chamber Bags

  • Compounded / Hospital Pharmacy-Prepared PN

• Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Pediatrics Alzheimer’s

  • Nutrition Deficiency

  • Cancer Care

  • Diabetes

  • Chronic Kidney Diseases

  • Orphan Diseases

  • Dysphagia

  • Pain Management

  • Malabsorption/GI Disorder/Diarrhea

  • Others

• Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Online

  • Retail

    • Retail Pharmacies

    • Supermarkets & Other Retail Outlets

  • Institutional

    • Public/Institutional Tender & Hospital Procurement

    • Direct Manufacturer Sales to Institutions

    • Medical & Pharmaceutical Distributors

    • Hospital Pharmacies

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • Mexico

  • South America

    • Colombia

    • Peru

    • Chile

    • Ecuador

    • Venezuela

    • Rest of South America (including Bolivia, Paraguay, Uruguay, Guyana, Suriname)

  • Central America

    • Panama

    • Costa Rica

    • Guatemala

    • El Salvador

    • Honduras

    • Nicaragua

    • Rest of Central America (including Belize)

  • Caribbean

    • Dominican Republic

    • Rest of the Caribbean (including Jamaica, Trinidad and Tobago, the Bahamas, Barbados, and other Caribbean markets)

  • Brazil

  • Argentina

Research Methodology

The Latin America parenteral nutrition market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each Latin America parenteral nutrition segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations